NanoLeaf Technologies

Toronto, Canada Founded: 2017 • Age: 9 yrs Acquired By Maricann
Nanotechnology-based drug delivery for oral therapeutics is developed.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About NanoLeaf Technologies

NanoLeaf Technologies is a company based in Toronto (Canada) founded in 2017 was acquired by Maricann in October 2017. NanoLeaf Technologies operates in a competitive market with competitors including Lyndra, i2o Therapeutics, Rani Therapeutics, Cure Pharmaceutical and Biora Therapeutics, among others.

  • Headquarter Toronto, Canada
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Maricann

    (Oct 27, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of NanoLeaf Technologies

Premium access

Detailed funding history for NanoLeaf Technologies

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in NanoLeaf Technologies

NanoLeaf Technologies has secured backing from 1 investor. Prominent investors backing the company include Maricann.

All
Investor Description Founded Year Domain Location
Cannabis is cultivated and processed for medicinal product supply.
Locked Locked Locked
Premium access

Investor details for NanoLeaf Technologies

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by NanoLeaf Technologies

Investments
Premium access

Investment portfolio details for NanoLeaf Technologies

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - NanoLeaf Technologies

Premium access

Detailed financials for NanoLeaf Technologies

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Nanoleaf Technologies Comparisons

NanoLeaf Technologies Primary company
Description
Nanotechnology-based drug delivery for oral therapeutics is ...
Location
Toronto, Canada
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for NanoLeaf Technologies

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of NanoLeaf Technologies

NanoLeaf Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lyndra, i2o Therapeutics, Rani Therapeutics, Cure Pharmaceutical and Biora Therapeutics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Innovates long-acting oral therapies to simplify patient medication regimens.
Locked Locked Locked
Oral drug delivery solutions are provided via liquid technology platform.
Locked Locked Locked
Technology for oral delivery of large drug molecules is developed.
Locked Locked Locked
Oral thin film-based drug delivery systems are developed.
Locked Locked Locked
Smart pills are developed for targeted gastrointestinal drug delivery.
Locked Locked Locked
Oral drug delivery systems for individualized micro-unit dosing are developed.
Premium access

Detailed competitors of NanoLeaf Technologies

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Nanoleaf Technologies

Premium access

Complete news archive for NanoLeaf Technologies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about NanoLeaf Technologies

NanoLeaf Technologies was founded in 2017.

NanoLeaf Technologies is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

Ben Ward is the current CEO of NanoLeaf Technologies.

NanoLeaf Technologies was founded in 2017 in Toronto, Canada, and operates in the biotechnology sector. Focus is placed on nanotechnology for drug-delivery systems targeting oral therapeutics. The VESIsorb platform is offered specifically for ingestible cannabinoid delivery. Operations center on advancing these technologies to improve therapeutic absorption and efficacy in the pharmaceutical industry.

NanoLeaf Technologies's top competitors include Rani Therapeutics, i2o Therapeutics and Cingulate.

NanoLeaf Technologies has 1 investor. Key investors include Maricann.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available